Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/10/02/2752481/0/en/Pneumagen-Announces-Successful-Clinical-Proof-of-Concept-for-its-Broad-Spectrum-Antiviral-Neumifil-in-Phase-2-Influenza-Human-Challenge-Study.html
https://www.globenewswire.com/news-release/2023/06/01/2680015/0/en/Pneumagen-raises-8m-to-accelerate-Phase-2-clinical-development-of-Neumifil-for-the-prevention-treatment-of-viral-respiratory-tract-infections.html
https://www.globenewswire.com/news-release/2023/04/18/2648658/0/en/Pneumagen-further-strengthens-IP-protection-for-lead-product-Neumifil-with-granting-of-US-composition-of-matter-patent.html
https://www.prnewswire.com/news-releases/pneumagen-creates-international-clinical-advisory-group-of-world-leading-respiratory-and-infectious-disease-experts-301634682.html
https://www.prnewswire.com/news-releases/pneumagen-announces-first-patient-dosed-in-phase-2-proof-of-concept-influenza-challenge-study-assessing-neumifil-an-intranasal-broad-spectrum-antiviral-301605881.html
https://www.prnewswire.com/news-releases/pneumagen-announces-positive-top-line-results-from-phase-1-study-evaluating-neumifil-a-product-designed-for-the-prevention-and-treatment-of-viral-respiratory-tract-infections-301545283.html
https://www.prnewswire.com/news-releases/pneumagen-announces-appointment-of-john-beadle-as-non-executive-director-301542879.html
https://www.prnewswire.com/news-releases/pneumagen-raises-3-8-million-to-advance-the-phase-ii-clinical-development-of-neumifil-a-pan-antiviral-intranasal-drug-for-the-prophylaxis-and-treatment-of-viral-respiratory-tract-infections-rtis-301463041.html
https://www.pharmiweb.com/pwtoday-story/pneumagen-announces-neumifil-is-efficacious-in-an-established-model-of-covid-19-infection
https://www.prnewswire.com/news-releases/pneumagen-announces-2-5m-fundraising-to-advance-universal-treatment-for-viral-respiratory-infections-into-the-clinic-this-year-301210969.html